Time of follow-up (years) | DOCE/TVF | Cardiac death | TV-MI | TLR | Definite/probable device thrombosis | Definite device thrombosis | |
Nairooz et al 5 | 2 | 1.53 (1.06 to 2.23) | NA | 1.94 (1.02 to 3.67) | 1.44 (0.81 to 2.54) | 2.85 (0.81 to 9.99) | 3.39 (1.46 to 7.88) |
Toyota et al 3 | 2 | 1.08 (0.76 to 1.54) | NA | NA | NA | 2.08 (1.02 to 4.26) | NA |
Stone et al 2 | 1 | 1.22 (0.91 to 1.64) | 1.26 (0.33 to 4.82) | 1.45 (1.02 to 2.07) | 1.14 (0.73 to 1.79) | 2.09 (0.92 to 4.75) | NA |
Cassese et al 9 | 1 | 1.20 (0.90 to 1.60) | NA | 1.36 (0.98 to 1.89) | 0.97 (0.66 to 1.43) | 1.99 (1.00 to 3.98) | NA |
*RR is reported. OR is reported for the other studies.
DOCE/TVF, device-oriented endpoint/target vessel failure; NA, not available; TV-MI, target vessel myocardial infarction; TLR, target lesion revascularisation.